2021. Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s44. DOI:https://doi.org/10.25251/skin.5.supp.44.